0001144204-18-007132.txt : 20180212
0001144204-18-007132.hdr.sgml : 20180212
20180212101916
ACCESSION NUMBER: 0001144204-18-007132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180208
FILED AS OF DATE: 20180212
DATE AS OF CHANGE: 20180212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLING ARNOLD P
CENTRAL INDEX KEY: 0001276711
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28385
FILM NUMBER: 18594492
MAIL ADDRESS:
STREET 1: C/O ADELPHIA HOLDINGS LLC
STREET 2: 545 MADISON AVE 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTALEX INC
CENTRAL INDEX KEY: 0001099215
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 912003490
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 131 COLUMBIA TURNPIKE
STREET 2: SUITE 1
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 215-862-9720
MAIL ADDRESS:
STREET 1: 131 COLUMBIA TURNPIKE
STREET 2: SUITE 1
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4
1
tv485521_form4.xml
FORM 4
X0306
4
2018-02-08
0
0001099215
PROTALEX INC
PRTX
0001276711
KLING ARNOLD P
410 PARK AVENUE
SUITE 1710
NEW YORK
NY
10022
1
1
1
0
President
Common Stock
22576087
I
By LLC
Common Stock
5000
D
Common Stock
62
I
By wife as UGMA custodian
Options
0.54
2018-02-08
4
A
0
600000
0
A
2018-02-08
2023-02-08
Common Stock
600000
600000
D
These securities are owned directly by Niobe Ventures, LLC and indirectly by Arnold P. Kling as manager of the LLC.
These securities are beneficially owned solely by Arnold P. Kling.
These shares are beneficially owned by Arnold P. Kling's wife as custodian for their children under the Uniform Gifts to Minors Act. Mr. Kling disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.
Granted on February 8, 2018 (the "Grant Date"), this option is exercisable to acquire 50% of the underlying shares on the Grant Date and 100% of the shares on or after the one-year anniversary of the Grant Date.
/s/ Arnold P. Kling, individually
2018-02-12